Analysed ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) News Sources
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Oil Surge, Higher Yields, Geopolitical Uncertainty
15-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Stalled Iran Peace Efforts, Inflation Concerns
18-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Tuesday Amid Uncertainty Surrounding US-Iran Talks
19-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Advance Pre-Bell Wednesday Ahead of Nvidia Earnings Report
20-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Uncertainty Surrounding US-Iran Talks
21-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Buoyed by Robust Corporate Earnings Season
22-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Rise Pre-Bell Tuesday Amid Renewed Hopes Around Middle East Peace Deal
26-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid S&P 500, Nasdaq Rally, Middle East Peace Optimism
27-05-2026
yahoo.com
What is the current price of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)?
The current price of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) is $171.63.
ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) absolute price change since previous trading day?
The absolute price change of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) since the previous trading day is $1.75.
ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) percentage price change since previous trading day?
The percentage price change of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) since the previous trading day is 1.0301%.
What is the most recent average sentiment score for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)?
The most recent average sentiment score for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) is 53 out of 100.
What is the most recent average sentiment for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)?
The most recent sentiment for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) is .
SEC-8K** Filing Available For ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.